Categories AlphaGraphs, Earnings, LATEST, Technology

Analog Devices stock falls on weak profit forecast

Analog Devices (ADI) said its earnings for the third quarter jumped six times, compared to last year when the bottom-line was dragged by some acquisition-related expenses and taxes. The stock opened Wednesday’s trading lower after the chipmaker guided fourth-quarter earnings below street view.

Net income jumped to $414.5 million, or $1.10 per share, from $68.9 million, or $0.18 per share a year ago. Non-GAAP EPS increased to $1.53 from $1.26 in the year-ago period.

Revenue grew 9.7% to $1.6 billion, primarily benefited from continued high demand for its products across B2B markets. For the fourth quarter, B2B sales are projected to increase low double digits year-over-year.

For the fourth quarter, the company predicts revenue of about $1.57 billion and EPS of about $1.07. Gross margin is anticipated to be about 68% and operating margin is projected to be 32% to 33%. Operating expenses are expected to be about $566 million for the fourth quarter.

Analog Devices third quarter 2018 earnings
Analog Devices Q3 2018 Earnings Infographics

“Our continued strong growth and profitability allowed us to achieve our leverage target three quarters ahead of our plan, and reinstate our share repurchase program as we enter the fourth quarter,” said Vincent Roche, President and CEO of Analog Devices.

In a separate release, Analog Devices said it has reinstated its share repurchase program and that its Board of Directors has authorized the company to purchase an additional $2 billion of its common stock.

The board of directors has also declared a quarterly cash dividend of $0.48 per outstanding share of common stock. The dividend is payable on September 12, 2018, to all shareholders of record on August 31, 2018.

The stock had risen over 23% in the past year and more than 7% year-to-date.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top